Education
About Us
Working with TipRanks
Follow Us
Novartis AG (CH:NOVN)
:NOVN
NOVN Stock Chart & Stats
Day’s Range― - ―
52-Week RangeCHF81.10 - CHF102.72
Previous CloseN/A
Volume858.75K
Average Volume (3M)2.69M
Market Cap
CHF187.60B
Enterprise ValueCHF208.96B
Total Cash (Recent Filing)CHF7.00B
Total Debt (Recent Filing)CHF32.64B
Price to Earnings (P/E)16.5
Beta0.84
Next Earnings
Oct 28, 2025EPS Estimate
1.81Last Dividend Ex-Date
Mar 11, 2025Dividend Yield3.52%
Share Statistics
EPS (TTM)1.95
Shares Outstanding2,112,421,900
10 Day Avg. Volume2,666,382
30 Day Avg. Volume2,691,630
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF101.00Price Target Upside1.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Bulls Say, Bears Say
Bulls Say
Clinical TrialsNovartis announced positive topline data for ianalumab in both NEPTUNUS 1 and 2 trials in Sjogren’s syndrome, an autoimmune disease with a significant patient population and unmet need given the lack of any approved treatment options.
EarningsNovartis reported a 2% EPS beat for the second quarter, indicating strong earnings performance.
Bears Say
Generic CompetitionThere is more to be done in the face of $32bn in sales which faces generic competition out to 2030.
Product PerformanceCosentyx experienced a slower growth trajectory, offsetting some of the strength seen in other products.
Novartis AG News
NOVN FAQ
What was Novartis AG’s price range in the past 12 months?
Novartis AG lowest stock price was CHF81.10 and its highest was CHF102.72 in the past 12 months.
What is Novartis AG’s market cap?
Novartis AG’s market cap is CHF187.60B.
When is Novartis AG’s upcoming earnings report date?
Novartis AG’s upcoming earnings report date is Oct 28, 2025 which is in 71 days.
How were Novartis AG’s earnings last quarter?
Novartis AG released its earnings results on Jul 17, 2025. The company reported CHF1.953 earnings per share for the quarter, beating the consensus estimate of CHF1.897 by CHF0.056.
Is Novartis AG overvalued?
According to Wall Street analysts Novartis AG’s price is currently Undervalued.
Does Novartis AG pay dividends?
Novartis AG pays a Annually dividend of CHF3.5 which represents an annual dividend yield of 3.52%. See more information on Novartis AG dividends here
What is Novartis AG’s EPS estimate?
Novartis AG’s EPS estimate is 1.81.
How many shares outstanding does Novartis AG have?
Novartis AG has 2,112,421,900 shares outstanding.
What happened to Novartis AG’s price movement after its last earnings report?
Novartis AG reported an EPS of CHF1.953 in its last earnings report, beating expectations of CHF1.897. Following the earnings report the stock price went down -1.871%.
Which hedge fund is a major shareholder of Novartis AG?
Currently, no hedge funds are holding shares in CH:NOVN
Company Description
Novartis AG
Novartis AG is a global healthcare company based in Switzerland that focuses on the research, development, manufacture, and marketing of innovative pharmaceuticals and generic medicines. The company operates in two main sectors: Innovative Medicines, which includes patented pharmaceuticals across various therapeutic areas such as oncology, cardiology, immunology, and neuroscience, and Sandoz, its generic and biosimilar division. Novartis is known for its strong pipeline of drugs, including well-known treatments like Gleevec for cancer and Cosentyx for autoimmune diseases.
NOVN Stock 12 Month Forecast
Average Price Target
CHF101.00
▲(1.52% Upside)
Technical Analysis
Ownership Overview
―
Insiders
8.47%
Mutual Funds
<0.01% Other Institutional Investors
79.80% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---